Bristol wins U.S. approval for lung cancer drug targeting rare genetic mutation
The Food and Drug Administration on Wednesday approved a new treatment for people with non-small cell lung cancer that contains a rare genetic alteration called
The Food and Drug Administration on Wednesday approved a new treatment for people with non-small cell lung cancer that contains a rare genetic alteration called
What You Should Know: – Omada Health, a leading virtual-first healthcare provider, today announced a groundbreaking partnership with Amazon Health Services. This collaboration brings Omada’s
As an undergraduate student in The University of Texas at Arlington’s Honors College, Hannah Selvarathinam knew she wanted to conduct research. Near the end of